Tang Capital Management BOLT Position
ExitedTang Capital Management exited their position in Bolt Biotherapeutics Inc. (BOLT) in Q4 2025, after holding the stock for 12 quarters.
The position was first reported in Q1 2023 and has been tracked across 12 quarterly 13F filings.
1 other tracked fund also holds BOLT.
There is an upcoming Phase 2 readout for BDC-4182 in 412 days (May 31, 2027), making the timing of Tang Capital's position particularly relevant.
About Bolt Biotherapeutics Inc.
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.
Full company profile →Short Interest
0.1%
0.0 days to cover
Tang Capital Management BOLT Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Exited | 0 | -66,879 | $0 |
| Q3 2025 | Decreased | 66,879 | -100,000 | $356K |
| Q2 2025 | Decreased | 166,879 | -3,645,894 | $963K |
| Q1 2025 | Held | 3,812,773 | — | $1.5M |
| Q4 2024 | Held | 3,812,773 | — | $2.0M |
| Q3 2024 | Held | 3,812,773 | — | $2.5M |
| Q2 2024 | Increased | 3,812,773 | +392,773 | $2.9M |
| Q1 2024 | Decreased | 3,420,000 | -232,244 | $4.8M |
| Q4 2023 | Increased | 3,652,244 | +95,204 | $4.1M |
| Q3 2023 | Increased | 3,557,040 | +223,237 | $3.7M |
| Q2 2023 | Increased | 3,333,803 | +1,706,250 | $4.3M |
| Q1 2023 | New | 1,627,553 | +1,627,553 | $2.3M |
Frequently Asked Questions
Does Tang Capital Management own BOLT?
No. Tang Capital Management exited their position in Bolt Biotherapeutics Inc. (BOLT) in Q4 2025. They previously held the stock for 12 quarters.
How many hedge funds own BOLT?
1 specialist biotech hedge fund currently holds BOLT, including OrbiMed Advisors. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Tang Capital Management first buy BOLT?
Tang Capital Management's position in BOLT was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Tang Capital Management's BOLT position increasing or decreasing?
Tang Capital Management completely exited their BOLT position in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
BOLTCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Tang Capital ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →